Company
Therini Bio
| Industry | clinical-stage biotech company developing fibrin-targeting immunotherapies for neurodegenerative diseases driven by vascular dysfunction |
|---|
Funding raised
| Company | Round | Date |
|---|---|---|
| Therini Bio | Series A | 2025-05-15 |
| Therini Bio | Series A Funding | 2023-04-27 |